Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Restrict the search for m cariprazine to a specific field?

Approximate Matches

2366
Any Name

2352
Standardized Name

1216
Reference Text / Citation

496
Display Name

346
Note

204
Reference URL

138
Related Substance Name

76
Organism Author

63
Relationship Comments

47
Mixture Component Name

30
root_modifications_structuralModifications_molecularFragment_refPname

28
Code Literal

22
Code Comments

17
root_modifications_structuralModifications_residueModified

17
Protein Structural Modification Residue

16
WIKIPEDIA

15
Code URL

9
Structure Stereo Comments

8
ALANWOOD

5
Protein Structural Modification Substance Name

Showing 2261 - 2270 of 4697 results

First page
Previous page
Next page
Next page

URALSAPONIN R

U6BLS4D8ER

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

URALSAPONIN P

PW27SD8M92

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

URALSAPONIN N

UN6XX5B366

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

TRIFLUSULFURON-METHYL

Y8AR13FYC0

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

3-METHOXY-4-METHYLAMPHETAMINE

BHS67KQE5Q

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (RACEMIC)

ACROTEBEN

4DAE97DDEP

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

BISMARK BROWN Y BASE

911CR7FM6S

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

6-BROMO-3-(1-METHYL-1H-PYRAZOL-4-YL)-5-((3S)-PIPERIDIN-3-YL)PYRAZOLO(1,5-A)PYRIMIDIN-7-AMINE

99Y1V29WVE

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Targets:

Serine/threonine-protein kinase Chk1

Conditions:

Hodgkin's lymphoma

Non-Hodgkin's lymphoma

Acute myeloid leukemia

MK-8776 (SCH-900776) is a checkpoint kinase 1 inhibitor which was developed by Merck for the treatment of cancer. The drug was tested in phase II clinical trials on patients suffering from acute myeloid leukemia (in combination with cytarabine) and in phase I on patients suffering from solid tumors or lymphoma (as monotherapy and in combination with gemcitabine).

PARATHION-METHYL

41BCL2O91D

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

FENOPROFEN, (R)-

S651283H42

Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ABSOLUTE)

Structure of URALSAPONIN R

ABSOLUTE

Structure of URALSAPONIN P

ABSOLUTE

Structure of URALSAPONIN N

ABSOLUTE

Structure of TRIFLUSULFURON-METHYL

ACHIRAL

TRIFLUSULFURON-METHYL

Structure of 3-METHOXY-4-METHYLAMPHETAMINE

RACEMIC

3-METHOXY-4-METHYLAMPHETAMINE

Structure of ACROTEBEN

ACHIRAL

Structure of BISMARK BROWN Y BASE

ACHIRAL

BISMARK BROWN Y BASE

Structure of 6-BROMO-3-(1-METHYL-1H-PYRAZOL-4-YL)-5-((3S)-PIPERIDIN-3-YL)PYRAZOLO(1,5-A)PYRIMIDIN-7-AMINE

ABSOLUTE

6-BROMO-3-(1-METHYL-1H-PYRAZOL-4-YL)-5-((3S)-PIPERIDIN-3-YL)PYRAZOLO(1,5-A)PYRIMIDIN-7-AMINE

Structure of PARATHION-METHYL

ACHIRAL

PARATHION-METHYL

Structure of FENOPROFEN, (R)-

ABSOLUTE

FENOPROFEN, (R)-

Showing 2261 - 2270 of 4697 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1